UNSPSC 41181545: Alpha-1-lipoprotein immunological test system

In this classification, a Alpha-1-lipoprotein immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Alpha-1-lipoprotein. US FDA regulates Alpha-1-lipoprotein immunological test system under 21 CFR 866.5580 and under FDA product code DER.

UNSPSC 41181545 Alpha-1-lipoprotein immunological test system is a Commodity code that does not align with the state and local contract opportunities recently posted under this classification. The recent solicitations tagged with this code reflect laboratory equipment, testing services, and instrumentation systems entirely outside the immunological testing scope — including optical surface profilometers (Valencia College), airfield photometric testing (Lee County Port Authority), drug discovery software (Jackson State University), electric meter test boards (City of Ocala), high-voltage capacitance measurement modules (Kissimmee Utility Authority), water quality analyzers (City of Tampa), sterilization equipment maintenance (Texas Department of State Health Services), atmospheric monitoring sensors (City of Phoenix), and insulating oil analysis services (Lubbock Power & Light). The mismatch between the code's stated commodity name and the actual work being procured suggests either a systematic tagging error or that this code currently sees little relevant activity for alpha-1-lipoprotein immunological test systems in state and local procurement.

The issuing bodies posting under this code span state health departments, municipal utilities, colleges and universities, county authorities, and special-purpose districts across Florida, Texas, Colorado, Oregon, and Arizona. No repeat buyers or jurisdictional concentration emerges from the recent opportunities. The geographic spread is diffuse with no dominant regional cluster. Without recent opportunities that actually match the immunological testing scope of UNSPSC 41181545, vendors should verify the code assignment directly with procuring agencies before pursuing opportunities currently tagged to this classification, as the mismatch suggests potential data quality issues rather than genuine demand for alpha-1-lipoprotein immunological test systems in state and local government.